Importance of assessing CK19 immunostaining in core biopsies in patients subjected to sentinel node study by OSNA

Virchows Archiv

Volumn 460, Issue 6, 2012, Pages 569-575

  Vilardell, Felip ^a   Novell, Anna ^a   Martin, Javier ^a   Santacana, Maria ^a   Velasco, Ana ^a   Diez Castro M J ^a   Cuevas, Dolors ^a   Panadés, M Jose ^a   González, Serafin ^a   Llombart, Antonio ^a   Iglesias, Edelmiro ^a   Matias Guiu, Xavier ^a  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

Author keywords

Basal like; Breast carcinoma; CK19; Luminal; OSNA

Indexed keywords

CYTOKERATIN 19; MESSENGER RNA;

ADULT; AGED; ARTICLE; ASSAY; BREAST CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-19; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 84863984595     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-012-1241-z     Document Type: Article

References (18)

1. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24, Review (Pubitemid 13215192)
2. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406:747-52
3. Rakha EA, Reis-Filho JS, Ellis IO (2008) Basal-like breast cancer: a critical review. J Clin Oncol 26:2568-81
4. Harvey JM, Clark GM, Osborne CK, Allred DC (1999) Estrogen receptor status by immunohistochemistry is superior to the ligandbinding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17:1474-81 (Pubitemid 29220854)
5. Goldhirsh A, Wood WC, Coates AS, Gelber RD, Thürlimann B, Senn HJ, Panel members (2011) Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer. Ann Oncol 22:1736-47
6. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van der Rijn M, Perou CM (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10:5367-74 (Pubitemid 39100473)
7. Collins LC, Martyniak A, Kandel MJ, Stadler ZK, Masciari S, Miron A, Richardson AL, Schnitt SJ, Garber JE (2009) Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triplenegative breast cancers. Am J Surg Pathol 33:1093-7
8. Tsujimoto M, Nakabayashi K, Yoshidome K, Kaneko T, Iwase T, Akiyama F, Kato Y, Tsuda H, Ueda S, Sato K, Tamaki Y, Noguchi S, Kataoka TR, Nakajima H, Komoike Y, Inaji H, Tsugawa K, Suzuki K, Nakamura S, Daitoh M, Otomo Y, Matsuura N (2007) One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res 13:4807-4816 (Pubitemid 47294788)
9. Visser M, Jiwa M, Horstman A, Brink AA, Pol RP, van Diest P, Snijders PJ, Meijer CJ (2008) Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Int J Cancer 122:2562-7 (Pubitemid 351590490)
10. Chu PG, Weiss LM (2002) Keratin expression in human tissues and neoplasms. Histopathology 40:403-39 (Pubitemid 34535443)
11. Abd El-Rehim DM, Pinder SE, Paish CE, Bell J, Blamey RW, Robertson JF, Nicholson RI, Ellis IO (2004) Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 203:661-71 (Pubitemid 38714103)
12. Parikh RR, Yang Q, Higgins SA, Haffty BG (2008) Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK19 expression. Int J Radiat Oncol Biol Phys 70:35-42 (Pubitemid 350251027)
13. Bernet L, Cano R, Martinez M, Dueñas B, Matias-Guiu X, Morell L, Palacios J, Rezola R, Robles-Frias M, Ruiz I, Velasco A, Vieites B, Sevilla F, Torro J, Medrano J, Ballester B (2011) Diagnosis of the sentinel lymph node in breast cancer: a reproducible molecular method: a multicentric Spanish study. Histopathology 58:863-9
14. Feldman S, Krishnamurthy S, Gillanders W, Gittleman M, Beitsch PD, Young PR, Streck CJ, Whitworth PW, Levine EA, Boolbol S, Han LK, Hermann R, Hoon DS, Giuliano AE, Meric-Bernstam F (2011) A novel automated assay for the rapid identification of metastatic breast carcinoma in sentinel lymph nodes. Cancer 117:2599-607
15. Schem C, Maass N, Bauerschlag DO, Carstensen MH, Löning T, Roder C, Batic O, Jonat W, Tiemann K (2009) One-step nucleic acid amplification-A molecular method for the detection of lymph node metastases in breast cancer patients; results of the German study group. Virchows Arch 454:203-10
16. Snook KL, Layer GT, Jackson PA, de Vries CS, Shousha S, Sinnett HD, Nigar E, Singhal H, Chia Y, Cunnick G, Kissin MW (2011) Multicenter evaluation of intraoperative molecular analysis of sentinel lymph nodes in breast carcinoma. Br J Surg 98:527-35
17. Castellano I, Macrí L, Deambrogio C, Balmativola D, Bussone R, Ala A, Coluccia C, Sapino A (2012) Reliability of whole sentinel lymph node analysis by one-step nucleic acid amplification for intraoperative diagnosis of breast cancer metastases. Ann Surg 255:334-42
18. Alvarenga CA, Paravidino PI, Alvarenga M, Dufloth R, Gomes M, Zeferino LC, Schmitt F (2011) Expression of CK19 in invasive breast carcinomas of special histological types: implications for the use of one-step nucleic acid amplification. J Clin Pathol 64:493-7